Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.

Area of Science:

• Oncology
• Biomarker Discovery
• Urology

Background:

• Circulating tumor cells (CTCs) are studied as cancer biomarkers but lack standardized urine isolation methods.
• Urine is an ideal noninvasive source for biomarkers, particularly for genitourinary cancers.
• Long noncoding RNAs (lncRNAs) are emerging as promising noninvasive urinary biomarkers.

Purpose of the Study:

• To review the clinical utility of urinary lncRNAs for diagnosing bladder and prostate cancers.
• To provide an update on recent advancements in the field.
• To highlight the potential of lncRNAs as noninvasive diagnostic tools.

Main Methods:

• Literature review of studies evaluating urinary lncRNAs for cancer diagnosis.
• Analysis of diagnostic accuracy of identified lncRNAs.
• Comparison with existing biomarker approaches, including CTCs.

Main Results:

• Growing body of research supports the diagnostic potential of urinary lncRNAs.
• Several lncRNAs show promising diagnostic accuracy for bladder and prostate cancers.
• Urinary lncRNAs offer a noninvasive alternative or adjunct to current diagnostic methods.

Conclusions:

• Urinary lncRNAs represent a significant advancement in noninvasive cancer diagnostics.
• Further research and standardization are needed to fully realize their clinical potential.
• lncRNAs hold promise for early detection and improved management of bladder and prostate cancers.